drugset / Trial / NCT01269541
MESS-study MRSA Eradication Study Skåne
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether systemic antibiotic treatment with rifampicin and clindamycine or trimethoprim-sulfa in addition to topical treatment with mupirocin is more effective than only topical treatment to eradicate MRSA in throatcarriers
Timeline
- Start
- 2011-03-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CLINDAMYCIN | Small molecule | 300 mg | — |
| Comparator | Rifampicin | Small molecule | 10 mg/kg | — |
| Comparator | Trimehoprimsulfa | Unknown | 80 mg | — |
| Comparator | Trimehoprimsulfa | Unknown | 400 mg | — |
| Comparator | Mupirocin | Small molecule | — | Topical |
Indications
No indication recorded.